BP-C1 in Treatment of Patients With Stage IV Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study and Additional Open-Label Treatment Phase.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.15_suppl.e12086
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2015
Authors
Publisher
American Society of Clinical Oncology (ASCO)